atorvastatin and Sensitivity and Specificity

Topics: Atorvastatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Maximum Tolerated Dose; Practice Guidelines as Topic; Pravastatin; Prognosis; Pyrroles; Quebec; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome

Topics: Adipose Tissue; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Biomarkers; Body Mass Index; C-Reactive Protein; Cholesterol, LDL; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pericardium; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome

Topics: Antioxidants; Ascorbic Acid; Atorvastatin; Confidence Intervals; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Non-alcoholic Fatty Liver Disease; Odds Ratio; Pyrroles; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Vitamin A

Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Heart Failure; Heptanoic Acids; Hospitalization; Humans; Male; Middle Aged; Neopterin; Pravastatin; Proportional Hazards Models; Pyrroles; Sensitivity and Specificity; Treatment Outcome

Topics: Adult; Aged; Atorvastatin; Biomarkers; Creatine Kinase; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Pyrroles; Rhabdomyolysis; Sensitivity and Specificity

Topics: Administration, Oral; Amlodipine; Atorvastatin; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Drug Stability; Heptanoic Acids; Humans; Isomerism; Linear Models; Pravastatin; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Therapeutic Equivalency

Topics: Adult; Aged; Apolipoproteins A; Atorvastatin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Lipoprotein(a); Logistic Models; Male; Middle Aged; Probability; Pyrroles; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Simvastatin; Statistics, Nonparametric; Treatment Outcome

Topics: Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Cholesterol; Coronary Circulation; Echocardiography, Stress; Female; Heptanoic Acids; Humans; Hyperplasia; Male; Multicenter Studies as Topic; Prospective Studies; Pyrroles; Sensitivity and Specificity; Tunica Intima

Topics: Anticholesteremic Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Follow-Up Studies; Heptanoic Acids; Humans; Male; Pyrroles; Sensitivity and Specificity; Switzerland; Time Factors; Triglycerides

Topics: Administration, Oral; Atorvastatin; Chromatography, High Pressure Liquid; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry

Topics: Atorvastatin; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Pravastatin; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry; Valsartan

Topics: Adolescent; Adult; Amlodipine; Atorvastatin; Chromatography, High Pressure Liquid; Humans; Linear Models; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Therapeutic Equivalency; Young Adult

Topics: Amlodipine; Anti-HIV Agents; Atorvastatin; Chromatography, High Pressure Liquid; Drug Interactions; HIV Infections; Humans; Linear Models; Metoprolol; Pravastatin; Reproducibility of Results; Rosuvastatin Calcium; Sensitivity and Specificity; Tandem Mass Spectrometry

Topics: Algorithms; Amlodipine; Atorvastatin; Linear Models; Micelles; Multivariate Analysis; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence

Topics: Aged; Atorvastatin; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Heptanoic Acids; Humans; Kaplan-Meier Estimate; Male; Matched-Pair Analysis; Middle Aged; Myocardial Infarction; Pyrroles; Retrospective Studies; Sensitivity and Specificity; Simvastatin; Treatment Outcome

Topics: Anticholesteremic Agents; Antifungal Agents; Atorvastatin; Candida; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Indoles; Microbial Sensitivity Tests; Microbiological Techniques; Pyrroles; Sensitivity and Specificity

Topics: Animals; Atorvastatin; Blotting, Western; Cells, Cultured; Disease Models, Animal; Endoglin; Fibrosis; Gene Expression Regulation; Hemodynamics; Heptanoic Acids; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; Muscle Cells; Myocardial Infarction; Polymerase Chain Reaction; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tetrazoles; Valine; Valsartan; Ventricular Remodeling

Topics: Acetaminophen; Animals; Atorvastatin; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Liver; Male; Metabolomics; Rats, Wistar; ROC Curve; Sensitivity and Specificity; Support Vector Machine

Topics: Acyl Coenzyme A; Atorvastatin; Carbon Isotopes; Chemistry, Pharmaceutical; Crystallization; Fluorine; Fluorine-19 Magnetic Resonance Imaging; Sensitivity and Specificity; Tablets

Topics: Anticholesteremic Agents; Atorvastatin; Buffers; Chromatography, High Pressure Liquid; Drug Contamination; Drug Stability; Fenofibrate; Heptanoic Acids; Hydrogen-Ion Concentration; Molecular Structure; Pyrroles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tablets; Time Factors

Topics: Animals; Anticholesteremic Agents; Atorvastatin; Cardiotonic Agents; Computer Systems; Contrast Media; Echocardiography; Heptanoic Acids; Image Enhancement; Male; Myocardial Reperfusion Injury; Pyrroles; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Ventricular Dysfunction, Left

Topics: Animals; Apoptosis; Atorvastatin; Biopsy, Needle; Disease Models, Animal; Heptanoic Acids; Immunohistochemistry; Kidney Calculi; Kidney Tubules; Male; Oxalates; Oxidative Stress; Probability; Pyrroles; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Statistics, Nonparametric; Superoxide Dismutase; Urinalysis

Topics: Analysis of Variance; Animals; Atorvastatin; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelium, Vascular; Heptanoic Acids; Male; Malondialdehyde; Mesenteric Arteries; Probability; Prostaglandins; Pyrroles; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sensitivity and Specificity; Vasodilation

Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Chromatography, High Pressure Liquid; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles; Sensitivity and Specificity; Simvastatin; Tandem Mass Spectrometry

Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Biometry; Carotid Arteries; Carotid Stenosis; Female; Heptanoic Acids; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Pattern Recognition, Automated; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Surface Properties; Ultrasonography

Topics: Aged; Angina Pectoris; Atorvastatin; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Coronary Angiography; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoassay; Male; Middle Aged; Muramidase; Predictive Value of Tests; Pyrroles; Sensitivity and Specificity; Severity of Illness Index; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Treatment Outcome; Up-Regulation

Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Benzazepines; Chromatography, Liquid; Drug Stability; Heptanoic Acids; Humans; Least-Squares Analysis; Male; Nevirapine; Pyrroles; Ramipril; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

Topics: Atorvastatin; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Stability; Fluorobenzenes; Heptanoic Acids; Humans; Hydrogen-Ion Concentration; Linear Models; Methanol; Pyrimidines; Pyrroles; Reproducibility of Results; Rosuvastatin Calcium; Sensitivity and Specificity; Sulfonamides; Water

Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Heptanoic Acids; Pharmaceutical Preparations; Pyrroles; Sensitivity and Specificity; Spectrophotometry; Tablets

Topics: Atorvastatin; Chromatography, High Pressure Liquid; Drug Stability; Heptanoic Acids; Humans; Linear Models; Liquid-Liquid Extraction; Male; Nevirapine; Niacin; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry

Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Ezetimibe; Heptanoic Acids; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Tablets

Topics: Adult; Aspirin; Atorvastatin; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Isosorbide; Pyrroles; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Ultrasonography, Interventional

Topics: Atorvastatin; Chromatography, Liquid; Heptanoic Acids; Molecular Structure; Novobiocin; Pharmaceutical Preparations; Pyrroles; Reference Standards; Roxithromycin; Sensitivity and Specificity; Solutions; Spectrometry, Mass, Electrospray Ionization; Water; Water Pollutants, Chemical

Topics: Adult; Aged; Apolipoproteins A; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Female; Fibronectins; Follow-Up Studies; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Probability; Prospective Studies; Pyrroles; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome

Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atorvastatin; Canada; Cardiovascular Diseases; Cost of Illness; Cost-Benefit Analysis; Direct Service Costs; Efficiency; Female; Health Care Costs; Health Expenditures; Heptanoic Acids; Humans; Hypolipidemic Agents; Life Expectancy; Male; Middle Aged; Primary Prevention; Pyrroles; Sensitivity and Specificity

Topics: Atorvastatin; Cholesterol, LDL; Coronary Disease; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Reproducibility of Results; Sensitivity and Specificity; Simvastatin; United States

Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Coronary Artery Disease; Cost-Benefit Analysis; Female; Germany; Health Care Costs; Heptanoic Acids; Humans; Hypertension; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome

Topics: Adult; Atorvastatin; Biomarkers; Case-Control Studies; CD40 Ligand; Cohort Studies; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; P-Selectin; Probability; Prognosis; Pyrroles; Reference Values; Sensitivity and Specificity; Severity of Illness Index

Topics: Atorvastatin; Biotransformation; Chromatography, High Pressure Liquid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Molecular Structure; Pyrroles; Reference Standards; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry

Topics: Atorvastatin; Chromatography, High Pressure Liquid; Heptanoic Acids; Humans; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet

Topics: Apoptosis; Atorvastatin; Cell Differentiation; Cell Division; Cell Proliferation; Cells, Cultured; Cytokines; Heptanoic Acids; Histamine Release; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin E; Lovastatin; Mast Cells; Probability; Pyridines; Pyrroles; Sensitivity and Specificity

Topics: Atorvastatin; Biological Availability; Calibration; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mass Spectrometry; Pyrroles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Therapeutic Equivalency

Topics: Adult; Apolipoprotein A-I; Apolipoprotein E2; Atorvastatin; Electrophoresis, Capillary; Heptanoic Acids; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Macromolecular Substances; Male; Phenotype; Phosphatidylcholines; Pyrroles; Sensitivity and Specificity; Time Factors; Triglycerides

Topics: Anticholesteremic Agents; Atorvastatin; Chromatography, High Pressure Liquid; Heptanoic Acids; Humans; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization

Topics: Amlodipine; Atorvastatin; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tablets

Topics: Angioplasty, Balloon, Coronary; Animals; Apolipoproteins E; Atherosclerosis; Atorvastatin; Biopsy, Needle; Cells, Cultured; Chemokine CCL19; Chemokine CCL21; Chemokines, CC; Coronary Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Gene Expression Regulation; Heptanoic Acids; Humans; Immunohistochemistry; In Vitro Techniques; Leukocytes, Mononuclear; Mice; Mice, Transgenic; Prognosis; Pyrroles; Receptors, CCR7; Receptors, Chemokine; Reference Values; Risk Factors; RNA, Messenger; Sensitivity and Specificity; Simvastatin; Treatment Outcome

Topics: Animals; Atorvastatin; Blotting, Western; Cattle; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Factor VIIa; Fibroblasts; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Phosphatidylserines; Pyrroles; Sensitivity and Specificity; Thromboplastin

Topics: Amlodipine; Anticholesteremic Agents; Atorvastatin; Calcium Channel Blockers; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Heptanoic Acids; Hydrolysis; Oxidative Stress; Photolysis; Pyrroles; Quality Control; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Temperature; Time Factors

Topics: Atorvastatin; Boron; Carbon; Diamond; Electrochemistry; Electrodes; Heptanoic Acids; Humans; Hydrogen-Ion Concentration; Hypolipidemic Agents; Molecular Conformation; Oxidation-Reduction; Pharmaceutical Preparations; Pyrroles; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Solutions; Tablets; Water

Topics: Amlodipine; Atorvastatin; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Heptanoic Acids; Models, Chemical; Molecular Structure; Pyrroles; Reproducibility of Results; Sensitivity and Specificity

Topics: Analysis of Variance; Animals; Apoptosis; Atorvastatin; bcl-2-Associated X Protein; Blotting, Western; Caspase 9; Cells, Cultured; Disease Models, Animal; Fas Ligand Protein; Female; Flow Cytometry; Hepatocytes; Heptanoic Acids; JNK Mitogen-Activated Protein Kinases; Male; Microscopy, Confocal; NF-kappa B; Probability; Pyrroles; Rats; Rats, Wistar; Sensitivity and Specificity

Topics: Atorvastatin; Chlorine; Halogenation; Heptanoic Acids; Mass Spectrometry; Methanol; Pharmaceutical Preparations; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Time Factors; Triclosan; Water; Water Pollutants, Chemical

Topics: Animals; Atorvastatin; Base Sequence; Blotting, Western; Cells, Cultured; Chemokines; Coronary Artery Disease; Coronary Vessels; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Molecular Sequence Data; Monocytes; Muscle, Smooth, Vascular; NF-kappa B; Polymerase Chain Reaction; Pyrroles; Rats; Reproducibility of Results; Sensitivity and Specificity

Topics: Anticholesteremic Agents; Atorvastatin; Clinical Trials as Topic; Coronary Disease; Heptanoic Acids; Humans; Myocardial Revascularization; Patient Selection; Pyrroles; Sensitivity and Specificity; Treatment Outcome

Topics: Apoptosis; Atorvastatin; Cell Survival; Cells, Cultured; Coronary Vessels; Cytokines; Dose-Response Relationship, Drug; Endothelium, Vascular; Fas Ligand Protein; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Membrane Glycoproteins; Muscle, Smooth, Vascular; Pravastatin; Pyrroles; Reference Values; Sensitivity and Specificity; Simvastatin

Topics: Aged; Atorvastatin; Canada; Coronary Disease; Cost-Benefit Analysis; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Sensitivity and Specificity

Topics: Acute Disease; Apoptosis; Atorvastatin; Cell Division; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Leukemia, Myeloid; Lovastatin; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Pyrroles; Sensitivity and Specificity; Tumor Cells, Cultured

Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Viscosity; Combined Modality Therapy; Erythrocyte Aggregation; Female; Fibrinogen; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Plasmapheresis; Probability; Prospective Studies; Pyrroles; Rheology; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome

Topics: Anticholesteremic Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Heptanoic Acids; Humans; Pyrroles; Sensitivity and Specificity; Triglycerides